Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
14,731
archived clinical trials in
Psychiatric

PRC-063 in Adolescent ADHD
A Phase III, Randomized, Double-Blind, Placebo-Controlled, Parallel-Arm, Multi-Center Study Measuring the Efficacy and Safety of PRC-063 in Adolescent ADHD Patients
Status: Enrolling
Updated:  7/7/2015
Houston Clinical Trials, LLC
mi
from
Houston, TX
PRC-063 in Adolescent ADHD
A Phase III, Randomized, Double-Blind, Placebo-Controlled, Parallel-Arm, Multi-Center Study Measuring the Efficacy and Safety of PRC-063 in Adolescent ADHD Patients
Status: Enrolling
Updated: 7/7/2015
Houston Clinical Trials, LLC
mi
from
Houston, TX
Click here to add this to my saved trials
PRC-063 in Adolescent ADHD
A Phase III, Randomized, Double-Blind, Placebo-Controlled, Parallel-Arm, Multi-Center Study Measuring the Efficacy and Safety of PRC-063 in Adolescent ADHD Patients
Status: Enrolling
Updated:  7/7/2015
Red Oak Psychiatry Associates, PA
mi
from
Houston, TX
PRC-063 in Adolescent ADHD
A Phase III, Randomized, Double-Blind, Placebo-Controlled, Parallel-Arm, Multi-Center Study Measuring the Efficacy and Safety of PRC-063 in Adolescent ADHD Patients
Status: Enrolling
Updated: 7/7/2015
Red Oak Psychiatry Associates, PA
mi
from
Houston, TX
Click here to add this to my saved trials
PRC-063 in Adolescent ADHD
A Phase III, Randomized, Double-Blind, Placebo-Controlled, Parallel-Arm, Multi-Center Study Measuring the Efficacy and Safety of PRC-063 in Adolescent ADHD Patients
Status: Enrolling
Updated:  7/7/2015
University of Texas Health Science Center at San Antonio
mi
from
San Antonio, TX
PRC-063 in Adolescent ADHD
A Phase III, Randomized, Double-Blind, Placebo-Controlled, Parallel-Arm, Multi-Center Study Measuring the Efficacy and Safety of PRC-063 in Adolescent ADHD Patients
Status: Enrolling
Updated: 7/7/2015
University of Texas Health Science Center at San Antonio
mi
from
San Antonio, TX
Click here to add this to my saved trials
PRC-063 in Adolescent ADHD
A Phase III, Randomized, Double-Blind, Placebo-Controlled, Parallel-Arm, Multi-Center Study Measuring the Efficacy and Safety of PRC-063 in Adolescent ADHD Patients
Status: Enrolling
Updated:  7/7/2015
Ericksen Research
mi
from
Clinton, UT
PRC-063 in Adolescent ADHD
A Phase III, Randomized, Double-Blind, Placebo-Controlled, Parallel-Arm, Multi-Center Study Measuring the Efficacy and Safety of PRC-063 in Adolescent ADHD Patients
Status: Enrolling
Updated: 7/7/2015
Ericksen Research
mi
from
Clinton, UT
Click here to add this to my saved trials
PRC-063 in Adolescent ADHD
A Phase III, Randomized, Double-Blind, Placebo-Controlled, Parallel-Arm, Multi-Center Study Measuring the Efficacy and Safety of PRC-063 in Adolescent ADHD Patients
Status: Enrolling
Updated:  7/7/2015
Physiciatric and Behavioral Solutions
mi
from
Salt Lake City, UT
PRC-063 in Adolescent ADHD
A Phase III, Randomized, Double-Blind, Placebo-Controlled, Parallel-Arm, Multi-Center Study Measuring the Efficacy and Safety of PRC-063 in Adolescent ADHD Patients
Status: Enrolling
Updated: 7/7/2015
Physiciatric and Behavioral Solutions
mi
from
Salt Lake City, UT
Click here to add this to my saved trials
PRC-063 in Adolescent ADHD
A Phase III, Randomized, Double-Blind, Placebo-Controlled, Parallel-Arm, Multi-Center Study Measuring the Efficacy and Safety of PRC-063 in Adolescent ADHD Patients
Status: Enrolling
Updated:  7/7/2015
NeuroScience, Inc.
mi
from
Herndon, VA
PRC-063 in Adolescent ADHD
A Phase III, Randomized, Double-Blind, Placebo-Controlled, Parallel-Arm, Multi-Center Study Measuring the Efficacy and Safety of PRC-063 in Adolescent ADHD Patients
Status: Enrolling
Updated: 7/7/2015
NeuroScience, Inc.
mi
from
Herndon, VA
Click here to add this to my saved trials
PRC-063 in Adolescent ADHD
A Phase III, Randomized, Double-Blind, Placebo-Controlled, Parallel-Arm, Multi-Center Study Measuring the Efficacy and Safety of PRC-063 in Adolescent ADHD Patients
Status: Enrolling
Updated:  7/7/2015
Northwest Clinical Research Center
mi
from
Bellvue, WA
PRC-063 in Adolescent ADHD
A Phase III, Randomized, Double-Blind, Placebo-Controlled, Parallel-Arm, Multi-Center Study Measuring the Efficacy and Safety of PRC-063 in Adolescent ADHD Patients
Status: Enrolling
Updated: 7/7/2015
Northwest Clinical Research Center
mi
from
Bellvue, WA
Click here to add this to my saved trials
PRC-063 in Adolescent ADHD
A Phase III, Randomized, Double-Blind, Placebo-Controlled, Parallel-Arm, Multi-Center Study Measuring the Efficacy and Safety of PRC-063 in Adolescent ADHD Patients
Status: Enrolling
Updated:  7/7/2015
Eastside Therapeutic Resource
mi
from
Kirkland, WA
PRC-063 in Adolescent ADHD
A Phase III, Randomized, Double-Blind, Placebo-Controlled, Parallel-Arm, Multi-Center Study Measuring the Efficacy and Safety of PRC-063 in Adolescent ADHD Patients
Status: Enrolling
Updated: 7/7/2015
Eastside Therapeutic Resource
mi
from
Kirkland, WA
Click here to add this to my saved trials
PRC-063 in Adolescent ADHD
A Phase III, Randomized, Double-Blind, Placebo-Controlled, Parallel-Arm, Multi-Center Study Measuring the Efficacy and Safety of PRC-063 in Adolescent ADHD Patients
Status: Enrolling
Updated:  7/7/2015
Mathison Centre for Mental Health Research and Education
mi
from
Calgary,
PRC-063 in Adolescent ADHD
A Phase III, Randomized, Double-Blind, Placebo-Controlled, Parallel-Arm, Multi-Center Study Measuring the Efficacy and Safety of PRC-063 in Adolescent ADHD Patients
Status: Enrolling
Updated: 7/7/2015
Mathison Centre for Mental Health Research and Education
mi
from
Calgary,
Click here to add this to my saved trials
Long-Term Safety of PRC-063 in Adolescents and Adults With ADHD
A Six-month, Open-label, Multi-center Study of the Safety and Efficacy of PRC-063 in Adults and Adolescents With ADHD
Status: Enrolling
Updated:  7/7/2015
UCLA
mi
from
Los Angeles, CA
Long-Term Safety of PRC-063 in Adolescents and Adults With ADHD
A Six-month, Open-label, Multi-center Study of the Safety and Efficacy of PRC-063 in Adults and Adolescents With ADHD
Status: Enrolling
Updated: 7/7/2015
UCLA
mi
from
Los Angeles, CA
Click here to add this to my saved trials
Long-Term Safety of PRC-063 in Adolescents and Adults With ADHD
A Six-month, Open-label, Multi-center Study of the Safety and Efficacy of PRC-063 in Adults and Adolescents With ADHD
Status: Enrolling
Updated:  7/7/2015
Synergy Clinical Research
mi
from
National City, CA
Long-Term Safety of PRC-063 in Adolescents and Adults With ADHD
A Six-month, Open-label, Multi-center Study of the Safety and Efficacy of PRC-063 in Adults and Adolescents With ADHD
Status: Enrolling
Updated: 7/7/2015
Synergy Clinical Research
mi
from
National City, CA
Click here to add this to my saved trials
Long-Term Safety of PRC-063 in Adolescents and Adults With ADHD
A Six-month, Open-label, Multi-center Study of the Safety and Efficacy of PRC-063 in Adults and Adolescents With ADHD
Status: Enrolling
Updated:  7/7/2015
Newport Beach Clinical Research Associates, Inc.
mi
from
Newport Beach, CA
Long-Term Safety of PRC-063 in Adolescents and Adults With ADHD
A Six-month, Open-label, Multi-center Study of the Safety and Efficacy of PRC-063 in Adults and Adolescents With ADHD
Status: Enrolling
Updated: 7/7/2015
Newport Beach Clinical Research Associates, Inc.
mi
from
Newport Beach, CA
Click here to add this to my saved trials
Long-Term Safety of PRC-063 in Adolescents and Adults With ADHD
A Six-month, Open-label, Multi-center Study of the Safety and Efficacy of PRC-063 in Adults and Adolescents With ADHD
Status: Enrolling
Updated:  7/7/2015
Orange County Neuro Phychiatry Research Centre
mi
from
Orange, CA
Long-Term Safety of PRC-063 in Adolescents and Adults With ADHD
A Six-month, Open-label, Multi-center Study of the Safety and Efficacy of PRC-063 in Adults and Adolescents With ADHD
Status: Enrolling
Updated: 7/7/2015
Orange County Neuro Phychiatry Research Centre
mi
from
Orange, CA
Click here to add this to my saved trials
Long-Term Safety of PRC-063 in Adolescents and Adults With ADHD
A Six-month, Open-label, Multi-center Study of the Safety and Efficacy of PRC-063 in Adults and Adolescents With ADHD
Status: Enrolling
Updated:  7/7/2015
Florida Clinical Research Center, LLC
mi
from
Bradenton, FL
Long-Term Safety of PRC-063 in Adolescents and Adults With ADHD
A Six-month, Open-label, Multi-center Study of the Safety and Efficacy of PRC-063 in Adults and Adolescents With ADHD
Status: Enrolling
Updated: 7/7/2015
Florida Clinical Research Center, LLC
mi
from
Bradenton, FL
Click here to add this to my saved trials
Long-Term Safety of PRC-063 in Adolescents and Adults With ADHD
A Six-month, Open-label, Multi-center Study of the Safety and Efficacy of PRC-063 in Adults and Adolescents With ADHD
Status: Enrolling
Updated:  7/7/2015
Sarkis Clinical Research
mi
from
Gainesville, FL
Long-Term Safety of PRC-063 in Adolescents and Adults With ADHD
A Six-month, Open-label, Multi-center Study of the Safety and Efficacy of PRC-063 in Adults and Adolescents With ADHD
Status: Enrolling
Updated: 7/7/2015
Sarkis Clinical Research
mi
from
Gainesville, FL
Click here to add this to my saved trials
Long-Term Safety of PRC-063 in Adolescents and Adults With ADHD
A Six-month, Open-label, Multi-center Study of the Safety and Efficacy of PRC-063 in Adults and Adolescents With ADHD
Status: Enrolling
Updated:  7/7/2015
Sarkis Clinical Trials
mi
from
Gainesville, FL
Long-Term Safety of PRC-063 in Adolescents and Adults With ADHD
A Six-month, Open-label, Multi-center Study of the Safety and Efficacy of PRC-063 in Adults and Adolescents With ADHD
Status: Enrolling
Updated: 7/7/2015
Sarkis Clinical Trials
mi
from
Gainesville, FL
Click here to add this to my saved trials
Long-Term Safety of PRC-063 in Adolescents and Adults With ADHD
A Six-month, Open-label, Multi-center Study of the Safety and Efficacy of PRC-063 in Adults and Adolescents With ADHD
Status: Enrolling
Updated:  7/7/2015
CNS Healthcare Jacksonville
mi
from
Jacksonville, FL
Long-Term Safety of PRC-063 in Adolescents and Adults With ADHD
A Six-month, Open-label, Multi-center Study of the Safety and Efficacy of PRC-063 in Adults and Adolescents With ADHD
Status: Enrolling
Updated: 7/7/2015
CNS Healthcare Jacksonville
mi
from
Jacksonville, FL
Click here to add this to my saved trials
Long-Term Safety of PRC-063 in Adolescents and Adults With ADHD
A Six-month, Open-label, Multi-center Study of the Safety and Efficacy of PRC-063 in Adults and Adolescents With ADHD
Status: Enrolling
Updated:  7/7/2015
Florida Clinical Research Center
mi
from
Maitlin, FL
Long-Term Safety of PRC-063 in Adolescents and Adults With ADHD
A Six-month, Open-label, Multi-center Study of the Safety and Efficacy of PRC-063 in Adults and Adolescents With ADHD
Status: Enrolling
Updated: 7/7/2015
Florida Clinical Research Center
mi
from
Maitlin, FL
Click here to add this to my saved trials
Long-Term Safety of PRC-063 in Adolescents and Adults With ADHD
A Six-month, Open-label, Multi-center Study of the Safety and Efficacy of PRC-063 in Adults and Adolescents With ADHD
Status: Enrolling
Updated:  7/7/2015
Clinical Neuroscience Solutions, Inc
mi
from
Orlando, FL
Long-Term Safety of PRC-063 in Adolescents and Adults With ADHD
A Six-month, Open-label, Multi-center Study of the Safety and Efficacy of PRC-063 in Adults and Adolescents With ADHD
Status: Enrolling
Updated: 7/7/2015
Clinical Neuroscience Solutions, Inc
mi
from
Orlando, FL
Click here to add this to my saved trials
Long-Term Safety of PRC-063 in Adolescents and Adults With ADHD
A Six-month, Open-label, Multi-center Study of the Safety and Efficacy of PRC-063 in Adults and Adolescents With ADHD
Status: Enrolling
Updated:  7/7/2015
Advanced Clinical Research
mi
from
Boise, ID
Long-Term Safety of PRC-063 in Adolescents and Adults With ADHD
A Six-month, Open-label, Multi-center Study of the Safety and Efficacy of PRC-063 in Adults and Adolescents With ADHD
Status: Enrolling
Updated: 7/7/2015
Advanced Clinical Research
mi
from
Boise, ID
Click here to add this to my saved trials
Long-Term Safety of PRC-063 in Adolescents and Adults With ADHD
A Six-month, Open-label, Multi-center Study of the Safety and Efficacy of PRC-063 in Adults and Adolescents With ADHD
Status: Enrolling
Updated:  7/7/2015
Center for Psychiatry and Behavioral Medicine, Inc.
mi
from
Las Vegas, NV
Long-Term Safety of PRC-063 in Adolescents and Adults With ADHD
A Six-month, Open-label, Multi-center Study of the Safety and Efficacy of PRC-063 in Adults and Adolescents With ADHD
Status: Enrolling
Updated: 7/7/2015
Center for Psychiatry and Behavioral Medicine, Inc.
mi
from
Las Vegas, NV
Click here to add this to my saved trials
Long-Term Safety of PRC-063 in Adolescents and Adults With ADHD
A Six-month, Open-label, Multi-center Study of the Safety and Efficacy of PRC-063 in Adults and Adolescents With ADHD
Status: Enrolling
Updated:  7/7/2015
The Medical Research Network, LLC
mi
from
New York, NY
Long-Term Safety of PRC-063 in Adolescents and Adults With ADHD
A Six-month, Open-label, Multi-center Study of the Safety and Efficacy of PRC-063 in Adults and Adolescents With ADHD
Status: Enrolling
Updated: 7/7/2015
The Medical Research Network, LLC
mi
from
New York, NY
Click here to add this to my saved trials
Long-Term Safety of PRC-063 in Adolescents and Adults With ADHD
A Six-month, Open-label, Multi-center Study of the Safety and Efficacy of PRC-063 in Adults and Adolescents With ADHD
Status: Enrolling
Updated:  7/7/2015
Wake Research Associates, LLC
mi
from
Raleigh, NC
Long-Term Safety of PRC-063 in Adolescents and Adults With ADHD
A Six-month, Open-label, Multi-center Study of the Safety and Efficacy of PRC-063 in Adults and Adolescents With ADHD
Status: Enrolling
Updated: 7/7/2015
Wake Research Associates, LLC
mi
from
Raleigh, NC
Click here to add this to my saved trials
Long-Term Safety of PRC-063 in Adolescents and Adults With ADHD
A Six-month, Open-label, Multi-center Study of the Safety and Efficacy of PRC-063 in Adults and Adolescents With ADHD
Status: Enrolling
Updated:  7/7/2015
University of Cincinnati
mi
from
Cincinnati, OH
Long-Term Safety of PRC-063 in Adolescents and Adults With ADHD
A Six-month, Open-label, Multi-center Study of the Safety and Efficacy of PRC-063 in Adults and Adolescents With ADHD
Status: Enrolling
Updated: 7/7/2015
University of Cincinnati
mi
from
Cincinnati, OH
Click here to add this to my saved trials
Long-Term Safety of PRC-063 in Adolescents and Adults With ADHD
A Six-month, Open-label, Multi-center Study of the Safety and Efficacy of PRC-063 in Adults and Adolescents With ADHD
Status: Enrolling
Updated:  7/7/2015
University of Cincinnati
mi
from
Cincinnati, OH
Long-Term Safety of PRC-063 in Adolescents and Adults With ADHD
A Six-month, Open-label, Multi-center Study of the Safety and Efficacy of PRC-063 in Adults and Adolescents With ADHD
Status: Enrolling
Updated: 7/7/2015
University of Cincinnati
mi
from
Cincinnati, OH
Click here to add this to my saved trials
Long-Term Safety of PRC-063 in Adolescents and Adults With ADHD
A Six-month, Open-label, Multi-center Study of the Safety and Efficacy of PRC-063 in Adults and Adolescents With ADHD
Status: Enrolling
Updated:  7/7/2015
IPS Research Company
mi
from
Oklahoma City, OK
Long-Term Safety of PRC-063 in Adolescents and Adults With ADHD
A Six-month, Open-label, Multi-center Study of the Safety and Efficacy of PRC-063 in Adults and Adolescents With ADHD
Status: Enrolling
Updated: 7/7/2015
IPS Research Company
mi
from
Oklahoma City, OK
Click here to add this to my saved trials
Long-Term Safety of PRC-063 in Adolescents and Adults With ADHD
A Six-month, Open-label, Multi-center Study of the Safety and Efficacy of PRC-063 in Adults and Adolescents With ADHD
Status: Enrolling
Updated:  7/7/2015
Oregon Center for Clinical Investigation
mi
from
Portland, OR
Long-Term Safety of PRC-063 in Adolescents and Adults With ADHD
A Six-month, Open-label, Multi-center Study of the Safety and Efficacy of PRC-063 in Adults and Adolescents With ADHD
Status: Enrolling
Updated: 7/7/2015
Oregon Center for Clinical Investigation
mi
from
Portland, OR
Click here to add this to my saved trials
Long-Term Safety of PRC-063 in Adolescents and Adults With ADHD
A Six-month, Open-label, Multi-center Study of the Safety and Efficacy of PRC-063 in Adults and Adolescents With ADHD
Status: Enrolling
Updated:  7/7/2015
Oregon Center for Clinical Investigation
mi
from
Salem, OR
Long-Term Safety of PRC-063 in Adolescents and Adults With ADHD
A Six-month, Open-label, Multi-center Study of the Safety and Efficacy of PRC-063 in Adults and Adolescents With ADHD
Status: Enrolling
Updated: 7/7/2015
Oregon Center for Clinical Investigation
mi
from
Salem, OR
Click here to add this to my saved trials
Long-Term Safety of PRC-063 in Adolescents and Adults With ADHD
A Six-month, Open-label, Multi-center Study of the Safety and Efficacy of PRC-063 in Adults and Adolescents With ADHD
Status: Enrolling
Updated:  7/7/2015
Clinical NeuroScience Solutions, Inc.
mi
from
Memphis, TN
Long-Term Safety of PRC-063 in Adolescents and Adults With ADHD
A Six-month, Open-label, Multi-center Study of the Safety and Efficacy of PRC-063 in Adults and Adolescents With ADHD
Status: Enrolling
Updated: 7/7/2015
Clinical NeuroScience Solutions, Inc.
mi
from
Memphis, TN
Click here to add this to my saved trials
Long-Term Safety of PRC-063 in Adolescents and Adults With ADHD
A Six-month, Open-label, Multi-center Study of the Safety and Efficacy of PRC-063 in Adults and Adolescents With ADHD
Status: Enrolling
Updated:  7/7/2015
FutureSearch Clinical Trials LP
mi
from
Austin, TX
Long-Term Safety of PRC-063 in Adolescents and Adults With ADHD
A Six-month, Open-label, Multi-center Study of the Safety and Efficacy of PRC-063 in Adults and Adolescents With ADHD
Status: Enrolling
Updated: 7/7/2015
FutureSearch Clinical Trials LP
mi
from
Austin, TX
Click here to add this to my saved trials
Long-Term Safety of PRC-063 in Adolescents and Adults With ADHD
A Six-month, Open-label, Multi-center Study of the Safety and Efficacy of PRC-063 in Adults and Adolescents With ADHD
Status: Enrolling
Updated:  7/7/2015
FutureSearch Trials of Dallas, LP
mi
from
Dallas, TX
Long-Term Safety of PRC-063 in Adolescents and Adults With ADHD
A Six-month, Open-label, Multi-center Study of the Safety and Efficacy of PRC-063 in Adults and Adolescents With ADHD
Status: Enrolling
Updated: 7/7/2015
FutureSearch Trials of Dallas, LP
mi
from
Dallas, TX
Click here to add this to my saved trials
Long-Term Safety of PRC-063 in Adolescents and Adults With ADHD
A Six-month, Open-label, Multi-center Study of the Safety and Efficacy of PRC-063 in Adults and Adolescents With ADHD
Status: Enrolling
Updated:  7/7/2015
Red Oak Psychiatry Associates, PA
mi
from
Houston, TX
Long-Term Safety of PRC-063 in Adolescents and Adults With ADHD
A Six-month, Open-label, Multi-center Study of the Safety and Efficacy of PRC-063 in Adults and Adolescents With ADHD
Status: Enrolling
Updated: 7/7/2015
Red Oak Psychiatry Associates, PA
mi
from
Houston, TX
Click here to add this to my saved trials
Long-Term Safety of PRC-063 in Adolescents and Adults With ADHD
A Six-month, Open-label, Multi-center Study of the Safety and Efficacy of PRC-063 in Adults and Adolescents With ADHD
Status: Enrolling
Updated:  7/7/2015
Houston Clinical Trials, LLC
mi
from
Houston, TX
Long-Term Safety of PRC-063 in Adolescents and Adults With ADHD
A Six-month, Open-label, Multi-center Study of the Safety and Efficacy of PRC-063 in Adults and Adolescents With ADHD
Status: Enrolling
Updated: 7/7/2015
Houston Clinical Trials, LLC
mi
from
Houston, TX
Click here to add this to my saved trials
Long-Term Safety of PRC-063 in Adolescents and Adults With ADHD
A Six-month, Open-label, Multi-center Study of the Safety and Efficacy of PRC-063 in Adults and Adolescents With ADHD
Status: Enrolling
Updated:  7/7/2015
Westex Clinical Investigations
mi
from
Lubbock, TX
Long-Term Safety of PRC-063 in Adolescents and Adults With ADHD
A Six-month, Open-label, Multi-center Study of the Safety and Efficacy of PRC-063 in Adults and Adolescents With ADHD
Status: Enrolling
Updated: 7/7/2015
Westex Clinical Investigations
mi
from
Lubbock, TX
Click here to add this to my saved trials
Long-Term Safety of PRC-063 in Adolescents and Adults With ADHD
A Six-month, Open-label, Multi-center Study of the Safety and Efficacy of PRC-063 in Adults and Adolescents With ADHD
Status: Enrolling
Updated:  7/7/2015
Ericksen Research
mi
from
Clinton, UT
Long-Term Safety of PRC-063 in Adolescents and Adults With ADHD
A Six-month, Open-label, Multi-center Study of the Safety and Efficacy of PRC-063 in Adults and Adolescents With ADHD
Status: Enrolling
Updated: 7/7/2015
Ericksen Research
mi
from
Clinton, UT
Click here to add this to my saved trials
Long-Term Safety of PRC-063 in Adolescents and Adults With ADHD
A Six-month, Open-label, Multi-center Study of the Safety and Efficacy of PRC-063 in Adults and Adolescents With ADHD
Status: Enrolling
Updated:  7/7/2015
Physiciatric and Behavioral Solutions
mi
from
Salt Lake City, UT
Long-Term Safety of PRC-063 in Adolescents and Adults With ADHD
A Six-month, Open-label, Multi-center Study of the Safety and Efficacy of PRC-063 in Adults and Adolescents With ADHD
Status: Enrolling
Updated: 7/7/2015
Physiciatric and Behavioral Solutions
mi
from
Salt Lake City, UT
Click here to add this to my saved trials
Long-Term Safety of PRC-063 in Adolescents and Adults With ADHD
A Six-month, Open-label, Multi-center Study of the Safety and Efficacy of PRC-063 in Adults and Adolescents With ADHD
Status: Enrolling
Updated:  7/7/2015
Woodstock Research Center at Neuropsychiatric Associates
mi
from
Woodstock, VT
Long-Term Safety of PRC-063 in Adolescents and Adults With ADHD
A Six-month, Open-label, Multi-center Study of the Safety and Efficacy of PRC-063 in Adults and Adolescents With ADHD
Status: Enrolling
Updated: 7/7/2015
Woodstock Research Center at Neuropsychiatric Associates
mi
from
Woodstock, VT
Click here to add this to my saved trials
Long-Term Safety of PRC-063 in Adolescents and Adults With ADHD
A Six-month, Open-label, Multi-center Study of the Safety and Efficacy of PRC-063 in Adults and Adolescents With ADHD
Status: Enrolling
Updated:  7/7/2015
NeuroScience, Inc.
mi
from
Herndon, VA
Long-Term Safety of PRC-063 in Adolescents and Adults With ADHD
A Six-month, Open-label, Multi-center Study of the Safety and Efficacy of PRC-063 in Adults and Adolescents With ADHD
Status: Enrolling
Updated: 7/7/2015
NeuroScience, Inc.
mi
from
Herndon, VA
Click here to add this to my saved trials
Long-Term Safety of PRC-063 in Adolescents and Adults With ADHD
A Six-month, Open-label, Multi-center Study of the Safety and Efficacy of PRC-063 in Adults and Adolescents With ADHD
Status: Enrolling
Updated:  7/7/2015
Northwest Clinical Research Center
mi
from
Bellvue, WA
Long-Term Safety of PRC-063 in Adolescents and Adults With ADHD
A Six-month, Open-label, Multi-center Study of the Safety and Efficacy of PRC-063 in Adults and Adolescents With ADHD
Status: Enrolling
Updated: 7/7/2015
Northwest Clinical Research Center
mi
from
Bellvue, WA
Click here to add this to my saved trials
Long-Term Safety of PRC-063 in Adolescents and Adults With ADHD
A Six-month, Open-label, Multi-center Study of the Safety and Efficacy of PRC-063 in Adults and Adolescents With ADHD
Status: Enrolling
Updated:  7/7/2015
Eastside Therapeutic Resource
mi
from
Kirkland, WA
Long-Term Safety of PRC-063 in Adolescents and Adults With ADHD
A Six-month, Open-label, Multi-center Study of the Safety and Efficacy of PRC-063 in Adults and Adolescents With ADHD
Status: Enrolling
Updated: 7/7/2015
Eastside Therapeutic Resource
mi
from
Kirkland, WA
Click here to add this to my saved trials
Long-Term Safety of PRC-063 in Adolescents and Adults With ADHD
A Six-month, Open-label, Multi-center Study of the Safety and Efficacy of PRC-063 in Adults and Adolescents With ADHD
Status: Enrolling
Updated:  7/7/2015
Dr. Margaret Weiss
mi
from
Vancouver,
Long-Term Safety of PRC-063 in Adolescents and Adults With ADHD
A Six-month, Open-label, Multi-center Study of the Safety and Efficacy of PRC-063 in Adults and Adolescents With ADHD
Status: Enrolling
Updated: 7/7/2015
Dr. Margaret Weiss
mi
from
Vancouver,
Click here to add this to my saved trials
PRC-063 in an ADULT Workplace Environment
A Randomized, Double-blind Study of the Time Course of Response of PRC-063 in Adults With ADHD in a Simulated Adult Workplace Environment
Status: Enrolling
Updated:  7/7/2015
AVIDA, Inc.
mi
from
Newport Beach, CA
PRC-063 in an ADULT Workplace Environment
A Randomized, Double-blind Study of the Time Course of Response of PRC-063 in Adults With ADHD in a Simulated Adult Workplace Environment
Status: Enrolling
Updated: 7/7/2015
AVIDA, Inc.
mi
from
Newport Beach, CA
Click here to add this to my saved trials
PRC-063 in an ADULT Workplace Environment
A Randomized, Double-blind Study of the Time Course of Response of PRC-063 in Adults With ADHD in a Simulated Adult Workplace Environment
Status: Enrolling
Updated:  7/7/2015
Center for Psychiatry and Behavioral Medicine, Inc.
mi
from
Las Vegas, NV
PRC-063 in an ADULT Workplace Environment
A Randomized, Double-blind Study of the Time Course of Response of PRC-063 in Adults With ADHD in a Simulated Adult Workplace Environment
Status: Enrolling
Updated: 7/7/2015
Center for Psychiatry and Behavioral Medicine, Inc.
mi
from
Las Vegas, NV
Click here to add this to my saved trials
Comparison of Megestrol and/or Omega-3 Fatty Acid-Enriched Nutritional Supplement in Treating Patients With Cancer-Related Weight Loss and Lack of Appetite
Phase III Double-Blind, Placebo-Controlled Randomized Comparison of Megestrol Acetate (Megace) Versus an N-3 Fatty Acid (EPA) Enriched Nutritional Supplement Versus Both for the Treatment of Cancer Cachexia and Anorexia
Status: Enrolling
Updated:  7/7/2015
CCOP - Scottsdale Oncology Program
mi
from
Scottsdale, AZ
Comparison of Megestrol and/or Omega-3 Fatty Acid-Enriched Nutritional Supplement in Treating Patients With Cancer-Related Weight Loss and Lack of Appetite
Phase III Double-Blind, Placebo-Controlled Randomized Comparison of Megestrol Acetate (Megace) Versus an N-3 Fatty Acid (EPA) Enriched Nutritional Supplement Versus Both for the Treatment of Cancer Cachexia and Anorexia
Status: Enrolling
Updated: 7/7/2015
CCOP - Scottsdale Oncology Program
mi
from
Scottsdale, AZ
Click here to add this to my saved trials
Comparison of Megestrol and/or Omega-3 Fatty Acid-Enriched Nutritional Supplement in Treating Patients With Cancer-Related Weight Loss and Lack of Appetite
Phase III Double-Blind, Placebo-Controlled Randomized Comparison of Megestrol Acetate (Megace) Versus an N-3 Fatty Acid (EPA) Enriched Nutritional Supplement Versus Both for the Treatment of Cancer Cachexia and Anorexia
Status: Enrolling
Updated:  7/7/2015
Mayo Clinic
mi
from
Jacksonville, FL
Comparison of Megestrol and/or Omega-3 Fatty Acid-Enriched Nutritional Supplement in Treating Patients With Cancer-Related Weight Loss and Lack of Appetite
Phase III Double-Blind, Placebo-Controlled Randomized Comparison of Megestrol Acetate (Megace) Versus an N-3 Fatty Acid (EPA) Enriched Nutritional Supplement Versus Both for the Treatment of Cancer Cachexia and Anorexia
Status: Enrolling
Updated: 7/7/2015
Mayo Clinic
mi
from
Jacksonville, FL
Click here to add this to my saved trials
Comparison of Megestrol and/or Omega-3 Fatty Acid-Enriched Nutritional Supplement in Treating Patients With Cancer-Related Weight Loss and Lack of Appetite
Phase III Double-Blind, Placebo-Controlled Randomized Comparison of Megestrol Acetate (Megace) Versus an N-3 Fatty Acid (EPA) Enriched Nutritional Supplement Versus Both for the Treatment of Cancer Cachexia and Anorexia
Status: Enrolling
Updated:  7/7/2015
CCOP - Illinois Oncology Research Association
mi
from
Peoria, IL
Comparison of Megestrol and/or Omega-3 Fatty Acid-Enriched Nutritional Supplement in Treating Patients With Cancer-Related Weight Loss and Lack of Appetite
Phase III Double-Blind, Placebo-Controlled Randomized Comparison of Megestrol Acetate (Megace) Versus an N-3 Fatty Acid (EPA) Enriched Nutritional Supplement Versus Both for the Treatment of Cancer Cachexia and Anorexia
Status: Enrolling
Updated: 7/7/2015
CCOP - Illinois Oncology Research Association
mi
from
Peoria, IL
Click here to add this to my saved trials
Comparison of Megestrol and/or Omega-3 Fatty Acid-Enriched Nutritional Supplement in Treating Patients With Cancer-Related Weight Loss and Lack of Appetite
Phase III Double-Blind, Placebo-Controlled Randomized Comparison of Megestrol Acetate (Megace) Versus an N-3 Fatty Acid (EPA) Enriched Nutritional Supplement Versus Both for the Treatment of Cancer Cachexia and Anorexia
Status: Enrolling
Updated:  7/7/2015
CCOP - Carle Cancer Center
mi
from
Urbana, IL
Comparison of Megestrol and/or Omega-3 Fatty Acid-Enriched Nutritional Supplement in Treating Patients With Cancer-Related Weight Loss and Lack of Appetite
Phase III Double-Blind, Placebo-Controlled Randomized Comparison of Megestrol Acetate (Megace) Versus an N-3 Fatty Acid (EPA) Enriched Nutritional Supplement Versus Both for the Treatment of Cancer Cachexia and Anorexia
Status: Enrolling
Updated: 7/7/2015
CCOP - Carle Cancer Center
mi
from
Urbana, IL
Click here to add this to my saved trials
Comparison of Megestrol and/or Omega-3 Fatty Acid-Enriched Nutritional Supplement in Treating Patients With Cancer-Related Weight Loss and Lack of Appetite
Phase III Double-Blind, Placebo-Controlled Randomized Comparison of Megestrol Acetate (Megace) Versus an N-3 Fatty Acid (EPA) Enriched Nutritional Supplement Versus Both for the Treatment of Cancer Cachexia and Anorexia
Status: Enrolling
Updated:  7/7/2015
CCOP - Cedar Rapids Oncology Project
mi
from
Cedar Rapids, IA
Comparison of Megestrol and/or Omega-3 Fatty Acid-Enriched Nutritional Supplement in Treating Patients With Cancer-Related Weight Loss and Lack of Appetite
Phase III Double-Blind, Placebo-Controlled Randomized Comparison of Megestrol Acetate (Megace) Versus an N-3 Fatty Acid (EPA) Enriched Nutritional Supplement Versus Both for the Treatment of Cancer Cachexia and Anorexia
Status: Enrolling
Updated: 7/7/2015
CCOP - Cedar Rapids Oncology Project
mi
from
Cedar Rapids, IA
Click here to add this to my saved trials
Comparison of Megestrol and/or Omega-3 Fatty Acid-Enriched Nutritional Supplement in Treating Patients With Cancer-Related Weight Loss and Lack of Appetite
Phase III Double-Blind, Placebo-Controlled Randomized Comparison of Megestrol Acetate (Megace) Versus an N-3 Fatty Acid (EPA) Enriched Nutritional Supplement Versus Both for the Treatment of Cancer Cachexia and Anorexia
Status: Enrolling
Updated:  7/7/2015
CCOP - Iowa Oncology Research Association
mi
from
Des Moines, IA
Comparison of Megestrol and/or Omega-3 Fatty Acid-Enriched Nutritional Supplement in Treating Patients With Cancer-Related Weight Loss and Lack of Appetite
Phase III Double-Blind, Placebo-Controlled Randomized Comparison of Megestrol Acetate (Megace) Versus an N-3 Fatty Acid (EPA) Enriched Nutritional Supplement Versus Both for the Treatment of Cancer Cachexia and Anorexia
Status: Enrolling
Updated: 7/7/2015
CCOP - Iowa Oncology Research Association
mi
from
Des Moines, IA
Click here to add this to my saved trials
Comparison of Megestrol and/or Omega-3 Fatty Acid-Enriched Nutritional Supplement in Treating Patients With Cancer-Related Weight Loss and Lack of Appetite
Phase III Double-Blind, Placebo-Controlled Randomized Comparison of Megestrol Acetate (Megace) Versus an N-3 Fatty Acid (EPA) Enriched Nutritional Supplement Versus Both for the Treatment of Cancer Cachexia and Anorexia
Status: Enrolling
Updated:  7/7/2015
Siouxland Hematology-Oncology
mi
from
Sioux City, IA
Comparison of Megestrol and/or Omega-3 Fatty Acid-Enriched Nutritional Supplement in Treating Patients With Cancer-Related Weight Loss and Lack of Appetite
Phase III Double-Blind, Placebo-Controlled Randomized Comparison of Megestrol Acetate (Megace) Versus an N-3 Fatty Acid (EPA) Enriched Nutritional Supplement Versus Both for the Treatment of Cancer Cachexia and Anorexia
Status: Enrolling
Updated: 7/7/2015
Siouxland Hematology-Oncology
mi
from
Sioux City, IA
Click here to add this to my saved trials